The Anti-Androgen Hydroxyflutamide and Androgens Inhibit Interleukin-6 Production by an Androgen-Responsive Human Osteoblastic Cell Line
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
While androgens clearly have significant skeletal effects, the paracrine mediators of androgen action on bone are at present unclear. Interleukin-6 (IL-6) is a candidate cytokine that is produced by osteoblastic lineage cells and promotes osteoclastogenesis and bone resorption. Here, we assessed constitutive as well as IL-1β– and tumor necrosis factor-α (TNF-α)–stimulated IL-6 mRNA expression by Northern analysis and protein secretion by immunoassay in a human androgen-responsive osteoblastic cell line (hFOB/AR-6) which contains ∼4000 androgen receptors (ARs)/nucleus. Treatment with 5α-dihydrotestosterone (DHT) dose-dependently inhibited constitutive and TNF-α/IL-1β–stimulated IL-6 mRNA steady-state levels in hFOB/AR-6 cells by 70–80% at 10−7 M. In addition, testosterone also suppressed TNF-α/IL-1β–stimulated IL-6 mRNA levels by 57%, while the adrenal androgen dehydroepiandrosterone had no effect. Of note, the specific AR antagonist, hydroxyflutamide, also inhibited IL-6 mRNA levels by 70%. Consistent with the Northern analyses, treatment with 5α-DHT, testosterone, and hydroxyflutamide also inhibited IL-6 protein production by 79%, 62%, and 71%, respectively (p < 0.001), while these agents had no effect on IL-6 soluble receptor levels. Finally, we demonstrated that hydroxyflutamide treatment of hFOB/AR-6 cells markedly inhibited the activation and binding of NF-κB (a known stimulator of IL-6 gene transcription) to its response element, thus providing a potential mechanism for its effect on IL-6 production by osteoblasts. These data are consistent with the hypothesis that suppression of osteoblast IL-6 production by androgens may mediate, at least in part, the antiresorptive effects of androgens on bone. Moreover, our findings also indicate that hydroxyflutamide, which is a known AR antagonist in most tissues, may function as a selective AR modulator for effects on IL-6 production by osteoblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Identification of androgen receptors in normal human osteoblast-like cells.
Colvard, D. S., Eriksen, E. F., Keeting, P. E., Wilson, E. M., Lubahn, D. B., French, F. S., Riggs, B. L., & Spelsberg, T. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.854 · Cited by 462 · cited 3×
“sion of alkaline phosphatase, type I collagen, and osteocalcin; formation of mineralized bone matrix) with the expression of functionally active AR (∼4000/nucleus), as present in other classical androgen target tissues, including prostate and bone.((10)) A similar effect, although of smaller magnitude, was also observ…”
BackgroundMethod
Research works printed but not linked: 37
- Orwoll, 1995, Osteoporosis in men, Endocr Rev, 16, 87, 10.1210/edrv-16-1-87 · DOI · Paper page
- Turner, 1994, Skeletal effects of estrogen, Endocr Rev, 15, 275
- Bagatell, 1996, Androgens in men: Uses and abuses, N Engl J Med, 334, 707, 10.1056/NEJM199603143341107 · DOI · Paper page
- Horowitz, 1993, Cytokines and estrogen in bone: Anti-osteoporotic effects, Science, 260, 626, 10.1126/science.8480174 · DOI · Paper page
- Vanderschueren, 1995, Androgens and bone, Calcif Tissue Int, 56, 341, 10.1007/BF00301598 · DOI
- Chang, 1988, Molecular cloning of human and rat complementary DNA encoding androgen receptors, Science, 240, 324, 10.1126/science.3353726 · DOI · Paper page
- Lubahn, 1988, The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate, Mol Endocrinol, 2, 1265, 10.1210/mend-2-12-1265 · DOI · Paper page
- Bellido, 1995, Regulation of interleukin-6, osteoclastogenesis, bone mass by androgens: The role of the androgen receptor, J Clin Invest, 95, 2886, 10.1172/JCI117995 · DOI · Paper page
- Mizuno, 1994, Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells, Calcif Tissue Int, 54, 325, 10.1007/BF00295958 · DOI
- Manolagas, 1995, Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis, N Engl J Med, 332, 305, 10.1056/NEJM199502023320506 · DOI · Paper page
- Passeri, 1993, Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal, Endocrinology, 133, 822, 10.1210/endo.133.2.8393776 · doi:10.1210/endo.133.2.8393776 · Paper page
- Girasole, 1992, 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens, J Clin Invest, 89, 883, 10.1172/JCI115668 · DOI · Paper page
- Jilka, 1992, Increased osteoclast development after estrogen loss: Mediation by interleukin-6, Science, 257, 88, 10.1126/science.1621100 · DOI · Paper page
- Kassem, 1996, Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors, J Bone Miner Res, 11, 193, 10.1002/jbmr.5650110208 · DOI · Paper page
- Poli, 1994, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion, EMBO J, 13, 1189, 10.1002/j.1460-2075.1994.tb06368.x · DOI · Paper page
- Pottratz, 1994, 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism, J Clin Invest, 93, 944, 10.1172/JCI117100 · DOI · Paper page
- Ray, 1994, Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor, J Biol Chem, 269, 12940, 10.1016/S0021-9258(18)99966-7 · DOI · Paper page
- Barnes, 1997, Nuclear factor-κB—A pivotal transcription factor in chronic inflammatory diseases, N Engl J Med, 336, 1066, 10.1056/NEJM199704103361506 · DOI · Paper page
- Hofbauer, 1997, Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene, J Cell Biochem, 66, 442, 10.1002/(SICI)1097-4644(19970915)66:4<542::AID-JCB13>3.0.CO;2-D · doi:10.1002/(sici)1097-4644(19970915)66:4<542::aid-jcb13>3.0.co;2-d
- Hofbauer, 1998, Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line, J Cell Biochem, 71, 96, 10.1002/(SICI)1097-4644(19981001)71:1<96::AID-JCB10>3.0.CO;2-G · DOI · Paper page
- Harris, 1995, Development and characterization of a conditionally immortalized human fetal osteoblastic cell line, J Bone Miner Res, 10, 178, 10.1002/jbmr.5650100203 · DOI · Paper page
- Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- Lehrach, 1977, RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination, Biochemistry, 16, 4743, 10.1021/bi00640a033 · DOI · Paper page
- Thomas, 1980, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose, Proc Natl Acad Sci USA, 77, 5201, 10.1073/pnas.77.9.5201 · DOI · Paper page
- Herrin, 1988, Rapid, reversible staining of Northern blots prior to hybridization, BioTechniques, 6, 196
- Feinberg, 1983, A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity, Anal Biochem, 132, 6, 10.1016/0003-2697(83)90418-9 · DOI · Paper page
- Yang, 1995, Fast hybridization solution for the detection of immobilized nucleic acids, BioTechniques, 18, 498
- Dignam, 1983, Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei, Nucleic Acids Res, 5, 1475, 10.1093/nar/11.5.1475 · DOI · Paper page
- Breuninger, 1993, Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes, Clin Immunol Immunopathol, 69, 205, 10.1006/clin.1993.1171 · DOI
- Harris, 1995, Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene, J Cell Biochem, 59, 193, 10.1002/jcb.240590209 · DOI
- Simard, 1997, Comparison of in vitro effects of the pure antiandrogen OH-flutamide, casodex, and nilutamide on androgen-sensitive parameters, Urology, 49, 580, 10.1016/S0090-4295(97)00029-0 · DOI
- McDonnell, 1997, Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone, Osteoporos Int, 7, S29, 10.1007/BF01674810 · DOI
- Stein, 1995, Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF κB and C/EPBβ, Mol Cell Biol, 15, 4971, 10.1128/MCB.15.9.4971 · DOI · Paper page
- Goulding, 1993, Flutamide-mediated androgen blockade evokes osteopenia in the female rat, J Bone Miner Res, 8, 763, 10.1002/jbmr.5650080615 · DOI
- Bertelloni, 1997, Androgen-receptor blockade does not impair bone mineral density in adolescent females, Calcif Tissue Int, 61, 1, 10.1007/s002239900282 · DOI
- Zhang, 1998, Orchiectomy increases bone marrow interleukin-6 levels in mice, Calcif Tissue Int, 62, 219, 10.1007/s002239900421 · DOI
- Giuliani, 1998, Bisphosphonates inhibit IL-6 production by human osteoblast-like cells, Scand J Rheumatol, 27, 38, 10.1080/030097498441155 · DOI · Paper page
Cited by
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Self-citationChanges in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794
Self-citationFalahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Self-citation
Metadata
- Authors
- Hofbauer, L. C., Ten, R. M., & Khosla, S.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08-01
- Volume
- 14
- Issue
- 8
- Pages
- 1330-1337
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2039342183
- Cited by
- 77
- References
- 2
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Anti-Androgen Hydroxyflutamide and Androgens Inhibit Interleukin-6 Production by an Androgen-Responsive Human Osteoblastic Cell Line. https://app.cochat.ai/papers/10.1359/jbmr.1999.14.8.1330
- The paper
- Hofbauer, L. C., Ten, R. M., & Khosla, S. (1999). The Anti-Androgen Hydroxyflutamide and Androgens Inhibit Interleukin-6 Production by an Androgen-Responsive Human Osteoblastic Cell Line. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.1999.14.8.1330
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.